Deepecho is a healthtech startup dedicated to improving prenatal care and democratizing fetal ultrasound globally. By leveraging AI, we significantly improve the effectiveness of ultrasound examinations, reducing fetal mortality by up to 20% and maternal mortality by 8%. Our innovative computer vision algorithms automate fetal ultrasound tasks, making the process more reliable, efficient, and cost-effective. We address key maternal and fetal health issues, including fetal growth restriction, preeclampsia, and postpartum hemorrhage, ensuring early detection of complications. Our research, published in the journal Nature, underscores our commitment to advancing prenatal care. Our vision for the next decade is to bring Deepecho to every corner of the globe, improving prenatal care for millions and aiming to end fetal mortality by 2030. We plan to expand our reach, enhance our AI capabilities, and support more healthcare facilities, especially in developing regions. By providing teleguidance and remote diagnosis, we ensure no mother or child is left behind in receiving quality care.
Our company develops advanced AI-driven tools for ultrasound diagnostics. Our technology significantly enhances the ability to diagnose using ultrasound by assisting radiologists and even minimally trained clinicians. This is particularly valuable in prenatal and maternal care, where our tools help in preventing birth defects and managing pregnancy complications. We are committed to making high-quality ultrasound diagnostics more accessible and effective worldwide, leveraging our platform’s mobile and hardware-agnostic capabilities.
Our product at DeepEcho addresses critical challenges in prenatal and maternal health by providing precise, AI-enhanced ultrasound diagnostics. This technology empowers radiologists and clinicians, especially in under-resourced settings, to make accurate diagnoses and manage risks more effectively during pregnancy. It bridges the gap in medical expertise and infrastructure by making sophisticated ultrasound analysis accessible and easy to use, ensuring better healthcare outcomes for mothers and infants globally.
